Published in Nature on December 14, 2011
MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov (2013) 3.33
microRNA involvement in human cancer. Carcinogenesis (2012) 2.98
Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell (2012) 2.50
Origins of metastatic traits. Cancer Cell (2013) 2.49
Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J (2012) 2.21
Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell (2014) 1.88
Mechanisms governing metastatic dormancy and reactivation. Cell (2013) 1.81
miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol (2013) 1.79
MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun (2013) 1.76
Extracellular metabolic energetics can promote cancer progression. Cell (2015) 1.74
Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol (2013) 1.73
HMGA2 is a driver of tumor metastasis. Cancer Res (2013) 1.66
Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics (2015) 1.65
Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta (2014) 1.53
Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival. Nat Cell Biol (2015) 1.51
Causes and consequences of microRNA dysregulation. Cancer J (2012) 1.51
A miR-19 regulon that controls NF-κB signaling. Nucleic Acids Res (2012) 1.43
MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev (2012) 1.34
MicroRNAs in common human diseases. Genomics Proteomics Bioinformatics (2012) 1.25
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res (2013) 1.21
Microenvironmental regulation of cancer metastasis by miRNAs. Trends Cell Biol (2013) 1.20
The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells. Mol Cancer (2013) 1.19
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer. J Exp Med (2013) 1.19
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget (2015) 1.17
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene (2015) 1.16
microRNA-mediated regulation of the tumor microenvironment. Cell Cycle (2013) 1.14
Regulation and dysregulation of 3'UTR-mediated translational control. Curr Opin Genet Dev (2013) 1.14
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res (2014) 1.13
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res (2015) 1.12
Friend or foe: the role of microRNA in chemotherapy resistance. Acta Pharmacol Sin (2013) 1.11
miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One (2013) 1.10
WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. Oncogene (2013) 1.09
MicroRNA regulons in tumor microenvironment. Oncogene (2014) 1.08
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene (2014) 1.05
MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis. Int J Mol Sci (2012) 1.04
MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol (2014) 1.03
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene (2013) 1.01
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia. Blood (2013) 1.00
Angiogenesis and hypoxia in the kidney. Nat Rev Nephrol (2013) 0.99
MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Ups J Med Sci (2012) 0.98
PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer. Br J Cancer (2013) 0.97
Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity. J Biol Chem (2014) 0.97
MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis (2015) 0.96
MicroRNAs in cancer therapeutic response: Friend and foe. World J Clin Oncol (2014) 0.96
MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLoS One (2014) 0.95
Non-coding RNA: a new frontier in regulatory biology. Natl Sci Rev (2014) 0.95
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis. J Clin Invest (2013) 0.94
Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer. Nat Cell Biol (2015) 0.94
Rewiring of an epithelial differentiation factor, miR-203, to inhibit human squamous cell carcinoma metastasis. Cell Rep (2014) 0.94
Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsis. Shock (2013) 0.93
Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells. J Biol Chem (2013) 0.93
Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res Ther (2013) 0.93
MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial. Br J Cancer (2013) 0.93
DNA "nano-claw": logic-based autonomous cancer targeting and therapy. J Am Chem Soc (2014) 0.92
MicroRNAs in the control of metastatic bone disease. Trends Endocrinol Metab (2014) 0.92
MicroRNAs: promising new antiangiogenic targets in cancer. Biomed Res Int (2014) 0.91
Programmable and multiparameter DNA-based logic platform for cancer recognition and targeted therapy. J Am Chem Soc (2014) 0.91
Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes. Breast Cancer Res Treat (2015) 0.91
MicroRNA polymorphisms and environmental smoke exposure as risk factors for oesophageal squamous cell carcinoma. PLoS One (2013) 0.91
MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Rep (2014) 0.90
RASAL2 activates RAC1 to promote triple-negative breast cancer progression. J Clin Invest (2014) 0.90
Phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1) binds and transfers phosphatidic acid. J Biol Chem (2012) 0.90
The antitumor potential of Interleukin-27 in prostate cancer. Oncotarget (2014) 0.90
Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer (2016) 0.89
Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma. BMC Cancer (2014) 0.89
IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells. Mol Cancer Ther (2013) 0.89
SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma. Nat Commun (2014) 0.89
Mechanisms of Metastatic Tumor Dormancy. J Clin Med (2013) 0.89
Overexpression and knockout of miR-126 both promote leukemogenesis. Blood (2015) 0.88
A brief primer on microRNAs and their roles in angiogenesis. Vasc Cell (2013) 0.88
Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis. Mol Cancer (2013) 0.88
A paracrine network regulates the cross-talk between human lung stem cells and the stroma. Nat Commun (2014) 0.87
Prometastatic GPCR CD97 is a direct target of tumor suppressor microRNA-126. ACS Chem Biol (2013) 0.86
Genome-wide analysis of microRNA and mRNA expression signatures in cancer. Acta Pharmacol Sin (2015) 0.86
New therapeutic targets for cancer bone metastasis. Trends Pharmacol Sci (2015) 0.86
Identification and characterization of microRNAs in Baylisascaris schroederi of the giant panda. Parasit Vectors (2013) 0.85
Phosphatidylinositol transfer proteins and instructive regulation of lipid kinase biology. Biochim Biophys Acta (2015) 0.85
Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats. J Cancer Res Clin Oncol (2015) 0.85
Targeting Breast Cancer Metastasis. Breast Cancer (Auckl) (2015) 0.85
Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival. PLoS One (2013) 0.84
Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling. Transl Oncol (2013) 0.84
MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential. J Zhejiang Univ Sci B (2015) 0.84
Identification of differentially expressed serum proteins in gastric adenocarcinoma. J Proteomics (2015) 0.83
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor. Nat Commun (2015) 0.83
Tumour-derived miRNAs and bone metastasis. Bonekey Rep (2015) 0.83
Prognostic significance of miR-126 in various cancers: a meta-analysis. Onco Targets Ther (2016) 0.83
ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis. Cancer Res (2016) 0.82
PTPRN2 and PLCβ1 promote metastatic breast cancer cell migration through PI(4,5)P2-dependent actin remodeling. EMBO J (2015) 0.82
The roles of microRNAs in the regulation of tumor metastasis. Cell Biosci (2015) 0.82
Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation. Proc Natl Acad Sci U S A (2014) 0.82
A one-two punch of miR-126/126* against metastasis. Nat Cell Biol (2013) 0.82
Prospective surface marker-based isolation and expansion of fetal endothelial colony-forming cells from human term placenta. Stem Cells Transl Med (2013) 0.81
Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study. J Transl Med (2015) 0.81
Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. Nat Commun (2015) 0.81
The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells. Mol Biol Cell (2012) 0.80
Linking epithelial-to-mesenchymal-transition and epigenetic modifications. Semin Cancer Biol (2012) 0.80
Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies. J Pathol (2016) 0.80
PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion. Cancer Cell (2016) 0.80
The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort. J Transl Med (2014) 0.80
Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol Cancer (2016) 0.80
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell (2006) 16.05
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev (1995) 9.54
Molecular basis of metastasis. N Engl J Med (2008) 8.19
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature (2007) 7.05
TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest (1999) 5.30
AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res (2010) 4.89
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer (2008) 2.52
A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood (2006) 2.41
miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett (2010) 2.17
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev (2011) 1.85
MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis. Cell Cycle (2009) 1.63
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma. Dis Model Mech (2009) 1.53
Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol (2005) 1.37
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med (2010) 4.96
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med (2011) 4.25
Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell (2012) 2.50
Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science (2012) 2.14
Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology (2008) 1.94
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev (2011) 1.85
Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol (2013) 1.73
Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab (2004) 1.22
Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction. Mol Cell Biol (2012) 1.21
Mouse Models of Lipodystrophy Key reagents for the understanding of the metabolic syndrome. Drug Discov Today Dis Models (2007) 1.10
Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am J Respir Crit Care Med (2013) 1.09
Differential transendothelial transport of adiponectin complexes. Cardiovasc Diabetol (2014) 0.86
microRNA regulation of cancer-endothelial interactions: vesicular microRNAs on the move…. EMBO J (2012) 0.77
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis. J Clin Invest (2016) 0.77
TARBP2 binding structured RNA elements drives metastasis. Cell Cycle (2014) 0.75
Cancer: Endothelial-cell killing promotes metastasis. Nature (2016) 0.75